View the LANZAAR 100 registration information details.
Back to drug list
ItemsDrug Registration information
ID171
No171
Brand NameLANZAAR 100
IngredientsLOSARTAN POTASSIUM 100 MG
Dosage FormFILM COATED TABLET
Primary PackagingALU-PVDC
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 3 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
Indications- TREATMENT OF HYPERTENSION (HTN), DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS( NIDDM) AND A HISTORY OF HYPERTENSION - STROKE RISK REDUCTION IN PATIENTS WITH HTN AND LEFT VENTRICULAR HYPERTROPHY"
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE OVAL BICONVEX FILM COATED TABLETS WITH ''BERLIN'' ON ONE SIDE AND SCORED BETWEEN L AND 100 ON THE OTHER SIDE
Note
License OwnerBERLIN PHARMA LAO CO.,LTD
ManufacturerBERLIN PHARMACEUTICAL INDUSTRY CO.,LTD
CountryTHAILAND
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 I 5044/21
FDD Registration Date23/11/2023
Expiry Date22/11/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA